Results 31 to 40 of about 21,622 (232)

Evaluation of new IPSS-Molecular model and comparison of different prognostic systems in patients with myelodysplastic syndrome

open access: yesBlood Science, 2023
A risk-adapted treatment strategy is of crucial importance in patients with myelodysplastic syndromes (MDS). Previous risk prognostic scoring systems did not integrate molecular abnormalities.
Jiale Ma   +6 more
doaj   +1 more source

The serum CRP levels are significantly correlated with (A) storage IPSS and (B) IPSS V/S ratio, but not with (C) total IPSS.

open access: yes, 2014
The serum CRP levels are significantly correlated with (A) storage IPSS and (B) IPSS V/S ratio, but not with (C) total IPSS.
Shiu-Dong Chung (398440)   +2 more
core   +1 more source

Comparison of sites by International Prostate Symptom Score (IPSS) severity category (IPSS).

open access: yes, 2017
Comparison of sites by International Prostate Symptom Score (IPSS) severity category (IPSS).
Francis Bajunirwe (269044)   +4 more
core   +1 more source

Correlation of Intravesical Prostatic Protrusion with Severity of Lower Urinary Tract Symptoms in Men With Symptomatic Benign Prostatic Hyperplasia at University of Nigeria Teaching Hospital, Ituku-Ozalla Enugu

open access: yesNigerian Journal of Medicine
Background Benign prostatic hyperplasia (BPH) is one of the causes of lower urinary tract symptoms (LUTS) in men above 50 years of age. It is known that the severity of LUTS (degree of bladder outlet obstruction) does not correlate with the size of the ...
Chukwunonso Anthony Iwenofu   +4 more
doaj   +1 more source

Associations Between PSA Levels and Erectile Dysfunction in the Patient with LUTS

open access: yesMedicine Science, 2016
Erectile dysfunction (ED) are common problem in males with lower urinary tract symptoms suggestive (LUTS).The aim of this study is to evaluate whether there is an association between PSA levels and ED or not. This study included total of 54 males aged 45-
Huseyin Celik   +4 more
doaj   +1 more source

Essential Updates in the Surgical Management of Inflammatory Bowel Disease: Current Topics From 2024 to Mid‐2026

open access: yesAnnals of Gastroenterological Surgery, EarlyView.
ABSTRACT Inflammatory bowel disease management has undergone a major transformation with the introduction of treat‐to‐target strategies and highly effective biologic and small‐molecule therapies. Although these advances have reduced the overall requirement for surgery, operative intervention remains essential for selected patients with ulcerative ...
Yoshiki Okita   +4 more
wiley   +1 more source

The International Prognostic Scoring System (IPSS) questionnaire.

open access: yes, 2023
The International Prognostic Scoring System (IPSS) questionnaire.
Justice Afrifa (5703674)   +6 more
core   +1 more source

Uroflowmetry Derived Index: A New Novel Metric in BPE Evaluation and Treatment Planning

open access: yesJournal of Urological Surgery
Objective: Benign prostatic enlargement (BPE) causes lower urinary tract symptoms (LUTS) in ageing men. While conventional diagnostic tools like the international prostate symptom score (IPSS) and uroflowmetry are routinely used, they often yield ...
Gautam Shubhankar, Pooja Nigade
doaj   +1 more source

Clinical significance of prostate volume and testosterone reduction on lower urinary tract symptoms in patients with prostate cancer undergoing androgen deprivation therapy

open access: yesScientific Reports, 2022
To investigate the effect of both prostate volume and serum testosterone changes on lower urinary tract symptoms in patients with prostate cancer undergoing androgen deprivation therapy.
Woo Jin Bang   +5 more
doaj   +1 more source

Human Monocytic Models Reveal Genotype‐Dependent Inflammatory Programs in VEXAS Syndrome

open access: yesArthritis &Rheumatology, Accepted Article.
Objectives VEXAS syndrome is a severe X‐linked autoinflammatory disorder caused by somatic mutations in ubiquitin‐like modifier activating enzyme 1 (UBA1), with clinical outcomes that vary by UBA1 genotype. We aimed to elucidate genotype‐specific inflammatory programs and identify potential therapeutic targets.
Kana Higashitani   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy